Divi’s Labs Q3 Result Review: Jefferies Hikes Target Price, But Goldman Sachs Remains Cautious

Jefferies appeared the most bullish on the counter, hiking the target price, while Morgan Stanley reduced the target price, citing a subdued environment in the Generics’ business.